India reported 2,51,209 new coronavirus cases in 24 hours along with 627 deaths, the health ministry said.

The daily active cases stands at 21,05,611 with the positivity rate at over 15 per cent.

There have been 3,47,443 recoveries in the last 24 hours, the health ministry informed.&nbsp;The country had reported 2,86,384 new coronavirus cases with 573 fatalities on Thursday.

Meanwhile, Kerala's health minister Veena George said the Omicron variant was found in 94 per cent samples in the state as central health minister Mansukh Mandaviya is set to hold a review meeting with southern states including with governments of Union Territories.

<a href="https://www.wionews.com/world/explainer-what-is-the-new-stealth-omicron-447976">Also Read:&nbsp;Explainer: What is the new 'stealth Omicron'?</a>

India's southern state of Tamil Nadu which has witnessed a surge in coronavirus cases reported 28,515 coronavirus cases and 53 deaths on Thursday.

Karnataka reported over 38,000 cases along with 49 deaths, the state health department said while adding that the number of active cases was at 3,28,711. The positivity rate stands at over 20 per cent in the state.

India's western state of Maharashtra which has been hit the hardest due to the virus reported a drop in COVID-19 cases recording 25,425 COVID-19 cases and 42 deaths in 24 hours.

The number of active cases in Maharashtra stands at over 2,00,000. India's capital Delhi reported 4,291 COVID-19 cases with 34 deaths in 24 hours on Thursday. The number of active cases in the capital stands at 33,175 with the positivity rate at over 9 per cent.

(With inputs from Agencies)

India reported 2,51,209 new coronavirus cases in 24 hours along with 627 deaths, the health ministry said. The daily active cases stands at 21,05,611 with the positivity rate at over 15 per cent.

India reported 2,51,209 new coronavirus cases in 24 hours along with 627 deaths, the health ministry said. The daily active cases stands at 21,05,611 with the positivity rate at over 15 per cent. There have been 3,47,443 recoveries in the last 24 hours, the health ministry informed. The country had reported 2,86,384 new coronavirus cases with 573 fatalities on Thursday. Meanwhile, Kerala's health minister Veena George said the Omicron variant was found in 94 per cent samples in the state as central health minister Mansukh Mandaviya is set to hold a review meeting with southern states including with governments of Union Territories. Also Read: Explainer: What is the new 'stealth Omicron'? India's southern state of Tamil Nadu which has witnessed a surge in coronavirus cases reported 28,515 coronavirus cases and 53 deaths on Thursday. Karnataka reported over 38,000 cases along with 49 deaths, the state health department said while adding that the number of active cases was at 3,28,711. The positivity rate stands at over 20 per cent in the state. India's western state of Maharashtra which has been hit the hardest due to the virus reported a drop in COVID-19 cases recording 25,425 COVID-19 cases and 42 deaths in 24 hours. The number of active cases in Maharashtra stands at over 2,00,000. India's capital Delhi reported 4,291 COVID-19 cases with 34 deaths in 24 hours on Thursday. The number of active cases in the capital stands at 33,175 with the positivity rate at over 9 per cent. (With inputs from Agencies)

India reports over 35k less coronavirus cases; 627 fatalities in 24 hours

France's pharmaceutical giant Sanofi has said that the United States will be the first country to receive coronavirus vaccine if they succesfully develop it.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/world/french-unemployment-rate-falls-down-to-78-lowest-in-11-years-298592" hreflang="en">French unemployment rate falls down to 7.8%; lowest in 11 years</a>

Sanofi has decided to do so because the United States were the first one's to fund the research. Chief Executive Officer Pauk Hudson during an interview to Bloomberg said: "the US government has the right to the largest pre-order because it's invested in taking the risk." He also said "that if we've helped you manufacture the doses at risk, we expect to get the doses first."

Also read:&nbsp;<a href="https://www.wionews.com/business-economy/un-forecasts-coronavirus-to-shrink-world-economy-by-32-indias-growth-rate-projected-to-slow-to-12-in-2020-298590" hreflang="en">UN forecasts coronavirus to shrink world economy by 3.2%; India's growth rate projected to slow to 1.2% in 2020</a>

After receiving a financial boost from the US in Febraury, the French-based pharmaceutical company tied up with a British pharmaceutical company GlaxoSmithKine.&nbsp;

Sanofi's statement has kept wondering everyone on the distribution of the vaccine if ever created. The plan for distribution would need to be concrete to prevent chaos.&nbsp;

Some in the United States have suggested that if the vaccines are released, their health workers will be among the first to get it. But the global distribution of the vaccine to complicate by politics and logistics.&nbsp;

Paul Hudson told Bloomberg that he has been pushing European leaders to invest more in vaccine. He said: "I've been campaigning in Europe to say the US will get vaccines first," Hudson said. "That's how it will be because the they've invested to try and protect their population, to restart their economy."

France's pharmaceutical giant Sanofi has said that the United States will be the first country to receive coronavirus vaccine if they succesfully develop it. Also read: French unemployment rate falls down to 7.

France's pharmaceutical giant Sanofi has said that the United States will be the first country to receive coronavirus vaccine if they succesfully develop it. Also read: French unemployment rate falls down to 7.8%; lowest in 11 years Sanofi has decided to do so because the United States were the first one's to fund the research. Chief Executive Officer Pauk Hudson during an interview to Bloomberg said: "the US government has the right to the largest pre-order because it's invested in taking the risk." He also said "that if we've helped you manufacture the doses at risk, we expect to get the doses first." Also read: UN forecasts coronavirus to shrink world economy by 3.2%; India's growth rate projected to slow to 1.2% in 2020 After receiving a financial boost from the US in Febraury, the French-based pharmaceutical company tied up with a British pharmaceutical company GlaxoSmithKine. Sanofi's statement has kept wondering everyone on the distribution of the vaccine if ever created. The plan for distribution would need to be concrete to prevent chaos. Some in the United States have suggested that if the vaccines are released, their health workers will be among the first to get it. But the global distribution of the vaccine to complicate by politics and logistics. Paul Hudson told Bloomberg that he has been pushing European leaders to invest more in vaccine. He said: "I've been campaigning in Europe to say the US will get vaccines first," Hudson said. "That's how it will be because the they've invested to try and protect their population, to restart their economy."

French pharmaceuticals Sanofi: US will be first country to receive COVID vaccine

coronavirus-in

Coronavirus In, News on Coronavirus In, stories on Coronavirus In, articles on Coronavirus In, Coronavirus In stories at Wion, Coronavirus In news, Coronavirus In latest news

coronavirus in

India reports over 35k less coronavirus cases; 627 fatalities in 24 hours

French pharmaceuticals Sanofi: US will be first country to receive COVID vaccine